The Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 booster for people aged 12 to 15, but it will need to get a final tick of approval before it is made available to the age group.
Like other age groups, people from the age of 12 are now recommended by the TGA to get a booster six months after their second COVID-19 vaccine dose.
"Regulatory approval of the booster dose for this age group has also been granted in Israel, the United Kingdom and the United States," it said.
The move follows Pfizer boosters being approved for 16 and 17-year-olds earlier this year.
But for the boosters to be made available to the younger cohort, they have to be included in the vaccine program — a decision made by the Australian Technical Group on Immunisation (ATAGI).
"ATAGI will provide advice shortly on whether this vaccine should be included in the [program] as the final step in the two green light approval process," the TGA said.
Both Pfizer and Moderna vaccines are available for 12 to 15-year-olds, following the TGA and ATAGI approving them for the age group and adding them to the jab rollout last year.
As at April 8, 52.3 per cent of eligible people aged 16 and over have had a booster shot.
